Schor AM - Search Results

1

A novel 'sandwich' assay for quantifying chemo-regulated cell migration within 3-dimensional matrices: wound healing cytokines exhibit distinct motogenic activities compared to the transmembrane assay.

Schor SL, Ellis IR, Harada K, Motegi K, Anderson AR, Chaplain MA, Keatch RP, Schor AM. Schor SL, et al. Among authors: schor am. Cell Motil Cytoskeleton. 2006 May;63(5):287-300. doi: 10.1002/cm.20123. Cell Motil Cytoskeleton. 2006. PMID: 16528704

2

EGF AND TGF-alpha motogenic activities are mediated by the EGF receptor via distinct matrix-dependent mechanisms.

Ellis IR, Schor AM, Schor SL. Ellis IR, et al. Among authors: schor sl, schor am. Exp Cell Res. 2007 Feb 15;313(4):732-41. doi: 10.1016/j.yexcr.2006.11.016. Epub 2006 Dec 5. Exp Cell Res. 2007. PMID: 17196962

3

Differential involvement of TGF-beta1 in mediating the motogenic effects of TSP-1 on endothelial cells, fibroblasts and oral tumour cells.

Motegi K, Harada K, Ohe G, Jones SJ, Ellis IR, Crouch DH, Schor SL, Schor AM. Motegi K, et al. Among authors: schor sl, schor am. Exp Cell Res. 2008 Aug 1;314(13):2323-33. doi: 10.1016/j.yexcr.2008.04.013. Epub 2008 May 9. Exp Cell Res. 2008. PMID: 18555217

4

Bistable switch in migration stimulating factor expression: regulation by the concerted signalling of transforming growth factor-β1 and the extracellular matrix.

Schor SL, Ellis IR, Jones SJ, Woolston AM, Schor AM. Schor SL, et al. Among authors: schor am. Int J Cancer. 2012 May 1;130(9):2024-32. doi: 10.1002/ijc.26213. Epub 2011 Aug 16. Int J Cancer. 2012. PMID: 21630266

5

Antagonistic effects of TGF-beta 1 and MSF on fibroblast migration and hyaluronic acid synthesis. Possible implications for dermal wound healing.

Ellis I, Grey AM, Schor AM, Schor SL. Ellis I, et al. Among authors: schor sl, schor am. J Cell Sci. 1992 Jul;102 ( Pt 3):447-56. doi: 10.1242/jcs.102.3.447. J Cell Sci. 1992. PMID: 1506427

6

Motogenic activity of IGD-containing synthetic peptides.

Schor SL, Ellis I, Banyard J, Schor AM. Schor SL, et al. Among authors: schor am. J Cell Sci. 1999 Nov;112 ( Pt 22):3879-88. doi: 10.1242/jcs.112.22.3879. J Cell Sci. 1999. PMID: 10547349

7

Angiogenesis and tumour progression: migration-stimulating factor as a novel target for clinical intervention.

Schor AM, Schor SL. Schor AM, et al. Eye (Lond). 2010 Mar;24(3):450-8. doi: 10.1038/eye.2009.314. Epub 2009 Dec 18. Eye (Lond). 2010. PMID: 20019766 Review.

8

Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells.

Schor SL, Ellis IR, Jones SJ, Baillie R, Seneviratne K, Clausen J, Motegi K, Vojtesek B, Kankova K, Furrie E, Sales MJ, Schor AM, Kay RA. Schor SL, et al. Among authors: schor am. Cancer Res. 2003 Dec 15;63(24):8827-36. Cancer Res. 2003. PMID: 14695199

9

The expression of migration stimulating factor, a potent oncofetal cytokine, is uniquely controlled by 3'-untranslated region-dependent nuclear sequestration of its precursor messenger RNA.

Kay RA, Ellis IR, Jones SJ, Perrier S, Florence MM, Schor AM, Schor SL. Kay RA, et al. Among authors: schor sl, schor am. Cancer Res. 2005 Dec 1;65(23):10742-9. doi: 10.1158/0008-5472.CAN-05-2038. Cancer Res. 2005. PMID: 16322219

10

Synthesis of an IGD peptidomimetic with motogenic activity.

Shpiro N, Ellis IR, Dines TJ, Schor AM, Schor SL, Norman DG, Marquez R. Shpiro N, et al. Among authors: schor sl, schor am. Mol Biosyst. 2005 Oct;1(4):318-20. doi: 10.1039/b509023g. Epub 2005 Aug 26. Mol Biosyst. 2005. PMID: 16880997

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters